Roche and Ascidian agree to $1.8bn neurological disease partnership
8-9 News
Researchers identify new major cause of inflammatory bowel disease
10-11 Dermatology News
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
12 DARWIN'S MEDICINE - Coach Tolstoy
The evolutionary lessons for Bayer’s management restructure
13 MIKE DIXON - DE&I – don’t throw the baby out with the bathwater
Collecting the right data in the right way for the right reasons
14 INNOVATIVE IMPACT BLOG - Mastering pharma capability development cogs
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
15 HEALTHCARE COMMUNICATIONS - Health misinformation: can pharma really have an impact?
16-18 MS AND AGEING - The impact of multiple sclerosis on ageing patients
Across almost every sector, brands are multiplying their investment in creativity
19-21 ANTIMICROBIAL RESISTANCE - Tackling the antibiotic resistance crisis
22-23 REMOTE HEALTH - Medical remote monitoring: a revolution driven by connected patches
Picking your omnichannel direction requires a disciplined, scientific approach
24 ADVERTORIAL HAVAS LYNX - Point.1: Your first point in people-centred precision marketing
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
25 TL SPROUT HEALTH SOLUTIONS - Reducing disparities in healthcare through shared decision-making
26-28 SHARED DECISION-MAKING - How HCPs and patients are partnering to transform care
29 TL TAKEDA - Shared decision-making in oncology – turning principles into practice
30-32 CLIENT/AGENCY PARTNERSHIPS - Client/agency partnerships – a marriage of science and creativity
33-35 AI & MEDICAL INNOVATION – The AI revolution in healthcare
‘Patient engagement is both a process and a behaviour throughout the drug life cycle’